nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—PSMB8—islet of Langerhans—gestational diabetes	0.068	0.0745	CbGeAlD
Carfilzomib—PSMB10—adipose tissue—gestational diabetes	0.0673	0.0737	CbGeAlD
Carfilzomib—PSMB5—islet of Langerhans—gestational diabetes	0.0601	0.0658	CbGeAlD
Carfilzomib—PSMB8—Glipizide—Glyburide—gestational diabetes	0.0584	1	CbGdCrCtD
Carfilzomib—PSMB1—islet of Langerhans—gestational diabetes	0.0525	0.0575	CbGeAlD
Carfilzomib—PSMB10—head—gestational diabetes	0.0517	0.0566	CbGeAlD
Carfilzomib—PSMB2—islet of Langerhans—gestational diabetes	0.0512	0.0561	CbGeAlD
Carfilzomib—PSMB1—embryo—gestational diabetes	0.0508	0.0556	CbGeAlD
Carfilzomib—PSMB2—embryo—gestational diabetes	0.0495	0.0543	CbGeAlD
Carfilzomib—PSMB8—adipose tissue—gestational diabetes	0.0434	0.0475	CbGeAlD
Carfilzomib—PSMB5—uterus—gestational diabetes	0.0392	0.0429	CbGeAlD
Carfilzomib—PSMB5—adipose tissue—gestational diabetes	0.0383	0.042	CbGeAlD
Carfilzomib—PSMB8—vagina—gestational diabetes	0.036	0.0395	CbGeAlD
Carfilzomib—PSMB1—uterus—gestational diabetes	0.0342	0.0375	CbGeAlD
Carfilzomib—PSMB1—adipose tissue—gestational diabetes	0.0335	0.0367	CbGeAlD
Carfilzomib—PSMB2—uterus—gestational diabetes	0.0334	0.0366	CbGeAlD
Carfilzomib—PSMB2—adipose tissue—gestational diabetes	0.0327	0.0358	CbGeAlD
Carfilzomib—PSMB5—vagina—gestational diabetes	0.0318	0.0349	CbGeAlD
Carfilzomib—PSMB1—vagina—gestational diabetes	0.0278	0.0305	CbGeAlD
Carfilzomib—PSMB2—vagina—gestational diabetes	0.0272	0.0297	CbGeAlD
Carfilzomib—PSMB1—head—gestational diabetes	0.0257	0.0282	CbGeAlD
Carfilzomib—PSMB2—head—gestational diabetes	0.0251	0.0275	CbGeAlD
Carfilzomib—ABCB1—islet of Langerhans—gestational diabetes	0.00782	0.00857	CbGeAlD
Carfilzomib—ABCB1—embryo—gestational diabetes	0.00757	0.00829	CbGeAlD
Carfilzomib—ABCB1—uterus—gestational diabetes	0.0051	0.00559	CbGeAlD
Carfilzomib—ABCB1—adipose tissue—gestational diabetes	0.00499	0.00547	CbGeAlD
Carfilzomib—ABCB1—vagina—gestational diabetes	0.00415	0.00454	CbGeAlD
Carfilzomib—ABCB1—head—gestational diabetes	0.00383	0.0042	CbGeAlD
Carfilzomib—PSMB10—Amino acid and derivative metabolism—GLS2—gestational diabetes	0.0016	0.0554	CbGpPWpGaD
Carfilzomib—PSMB9—Amino acid and derivative metabolism—GLS2—gestational diabetes	0.00159	0.0551	CbGpPWpGaD
Carfilzomib—PSMB5—Amino acid and derivative metabolism—GLS2—gestational diabetes	0.00121	0.042	CbGpPWpGaD
Carfilzomib—PSMB1—Amino acid and derivative metabolism—GLS2—gestational diabetes	0.00121	0.042	CbGpPWpGaD
Carfilzomib—PSMB2—Amino acid and derivative metabolism—GLS2—gestational diabetes	0.00121	0.042	CbGpPWpGaD
Carfilzomib—PSMB8—Amino acid and derivative metabolism—GLS2—gestational diabetes	0.0012	0.0414	CbGpPWpGaD
Carfilzomib—ABCB1—HIF-1-alpha transcription factor network—GCK—gestational diabetes	0.000449	0.0155	CbGpPWpGaD
Carfilzomib—PSMB10—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000373	0.0129	CbGpPWpGaD
Carfilzomib—PSMB9—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000371	0.0128	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—GGCT—gestational diabetes	0.000336	0.0116	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—GGCT—gestational diabetes	0.000335	0.0116	CbGpPWpGaD
Carfilzomib—PSMB10—B Cell Activation—FGF2—gestational diabetes	0.000329	0.0114	CbGpPWpGaD
Carfilzomib—PSMB9—B Cell Activation—FGF2—gestational diabetes	0.000328	0.0113	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—GLS2—gestational diabetes	0.000294	0.0102	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—GLS2—gestational diabetes	0.000293	0.0101	CbGpPWpGaD
Carfilzomib—PSMB1—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000282	0.00977	CbGpPWpGaD
Carfilzomib—PSMB2—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000282	0.00977	CbGpPWpGaD
Carfilzomib—PSMB5—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000282	0.00977	CbGpPWpGaD
Carfilzomib—PSMB8—Downstream signaling events of B Cell Receptor (BCR)—FGF2—gestational diabetes	0.000278	0.00963	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—GGCT—gestational diabetes	0.000255	0.00882	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—GGCT—gestational diabetes	0.000255	0.00882	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—GGCT—gestational diabetes	0.000255	0.00882	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—GGCT—gestational diabetes	0.000251	0.0087	CbGpPWpGaD
Carfilzomib—PSMB1—B Cell Activation—FGF2—gestational diabetes	0.000249	0.00863	CbGpPWpGaD
Carfilzomib—PSMB5—B Cell Activation—FGF2—gestational diabetes	0.000249	0.00863	CbGpPWpGaD
Carfilzomib—PSMB2—B Cell Activation—FGF2—gestational diabetes	0.000249	0.00863	CbGpPWpGaD
Carfilzomib—PSMB8—B Cell Activation—FGF2—gestational diabetes	0.000246	0.00851	CbGpPWpGaD
Carfilzomib—PSMB10—Apoptosis—TNF—gestational diabetes	0.000241	0.00833	CbGpPWpGaD
Carfilzomib—PSMB9—Apoptosis—TNF—gestational diabetes	0.00024	0.00829	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—MBL2—gestational diabetes	0.00023	0.00797	CbGpPWpGaD
Carfilzomib—ABCB1—HIF-1-alpha transcription factor network—LEP—gestational diabetes	0.00023	0.00795	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—MBL2—gestational diabetes	0.000229	0.00793	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—GLS2—gestational diabetes	0.000223	0.00771	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—GLS2—gestational diabetes	0.000223	0.00771	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—GLS2—gestational diabetes	0.000223	0.00771	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—GLS2—gestational diabetes	0.00022	0.0076	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—RBP4—gestational diabetes	0.000215	0.00742	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—RBP4—gestational diabetes	0.000214	0.00739	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—LEPR—gestational diabetes	0.000195	0.00675	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—LEPR—gestational diabetes	0.000194	0.00671	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—NAMPT—gestational diabetes	0.000192	0.00666	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—NAMPT—gestational diabetes	0.000192	0.00663	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—GCK—gestational diabetes	0.000191	0.00662	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—GCK—gestational diabetes	0.00019	0.00658	CbGpPWpGaD
Carfilzomib—PSMB5—Apoptosis—TNF—gestational diabetes	0.000182	0.00631	CbGpPWpGaD
Carfilzomib—PSMB1—Apoptosis—TNF—gestational diabetes	0.000182	0.00631	CbGpPWpGaD
Carfilzomib—PSMB2—Apoptosis—TNF—gestational diabetes	0.000182	0.00631	CbGpPWpGaD
Carfilzomib—PSMB8—Apoptosis—TNF—gestational diabetes	0.00018	0.00622	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—MBL2—gestational diabetes	0.000175	0.00604	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—MBL2—gestational diabetes	0.000175	0.00604	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—MBL2—gestational diabetes	0.000175	0.00604	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—MBL2—gestational diabetes	0.000172	0.00596	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—RBP4—gestational diabetes	0.000163	0.00563	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—RBP4—gestational diabetes	0.000163	0.00563	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—RBP4—gestational diabetes	0.000163	0.00563	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—NAMPT—gestational diabetes	0.000161	0.00558	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—NAMPT—gestational diabetes	0.00016	0.00555	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—RBP4—gestational diabetes	0.00016	0.00555	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—GCK—gestational diabetes	0.00016	0.00554	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—GCK—gestational diabetes	0.000159	0.00551	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—MTNR1B—gestational diabetes	0.000154	0.00533	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—MTNR1B—gestational diabetes	0.000153	0.00531	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—RBP4—gestational diabetes	0.00015	0.0052	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—RBP4—gestational diabetes	0.00015	0.00517	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—LEPR—gestational diabetes	0.000148	0.00511	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—LEPR—gestational diabetes	0.000148	0.00511	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—LEPR—gestational diabetes	0.000148	0.00511	CbGpPWpGaD
Carfilzomib—PSMB10—Gene Expression—AR—gestational diabetes	0.000146	0.00507	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—NAMPT—gestational diabetes	0.000146	0.00505	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—NAMPT—gestational diabetes	0.000146	0.00505	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—NAMPT—gestational diabetes	0.000146	0.00505	CbGpPWpGaD
Carfilzomib—PSMB9—Gene Expression—AR—gestational diabetes	0.000146	0.00504	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—LEPR—gestational diabetes	0.000146	0.00504	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—GCK—gestational diabetes	0.000145	0.00501	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—GCK—gestational diabetes	0.000145	0.00501	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—GCK—gestational diabetes	0.000145	0.00501	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—NAMPT—gestational diabetes	0.000144	0.00497	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—GCK—gestational diabetes	0.000143	0.00494	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—AR—gestational diabetes	0.000137	0.00472	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—FGF2—gestational diabetes	0.000133	0.00459	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—FGF2—gestational diabetes	0.000132	0.00457	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—NAMPT—gestational diabetes	0.000122	0.00423	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—NAMPT—gestational diabetes	0.000122	0.00423	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—NAMPT—gestational diabetes	0.000122	0.00423	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—GCK—gestational diabetes	0.000121	0.0042	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—GCK—gestational diabetes	0.000121	0.0042	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—GCK—gestational diabetes	0.000121	0.0042	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—NAMPT—gestational diabetes	0.00012	0.00417	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—GCK—gestational diabetes	0.00012	0.00414	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—CYP19A1—gestational diabetes	0.000117	0.00405	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—MTNR1B—gestational diabetes	0.000117	0.00404	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—MTNR1B—gestational diabetes	0.000117	0.00404	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—MTNR1B—gestational diabetes	0.000117	0.00404	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—CYP19A1—gestational diabetes	0.000117	0.00403	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—MTNR1B—gestational diabetes	0.000115	0.00399	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—RBP4—gestational diabetes	0.000114	0.00394	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—RBP4—gestational diabetes	0.000114	0.00394	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—RBP4—gestational diabetes	0.000114	0.00394	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—RBP4—gestational diabetes	0.000112	0.00388	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—AR—gestational diabetes	0.000111	0.00384	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—AR—gestational diabetes	0.000111	0.00384	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—AR—gestational diabetes	0.000111	0.00384	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—AR—gestational diabetes	0.000109	0.00379	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—FGF2—gestational diabetes	0.000101	0.00348	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—FGF2—gestational diabetes	0.000101	0.00348	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—FGF2—gestational diabetes	0.000101	0.00348	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—FGF2—gestational diabetes	9.91e-05	0.00343	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—TNF—gestational diabetes	9.21e-05	0.00318	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—CYP19A1—gestational diabetes	8.87e-05	0.00307	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—CYP19A1—gestational diabetes	8.87e-05	0.00307	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—CYP19A1—gestational diabetes	8.87e-05	0.00307	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—CYP19A1—gestational diabetes	8.75e-05	0.00303	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—FGF2—gestational diabetes	8.05e-05	0.00278	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—FGF2—gestational diabetes	8.01e-05	0.00277	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—GCK—gestational diabetes	7.62e-05	0.00264	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GGCT—gestational diabetes	7.5e-05	0.0026	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—FGF2—gestational diabetes	7.46e-05	0.00258	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—FGF2—gestational diabetes	7.43e-05	0.00257	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—FGF2—gestational diabetes	7.39e-05	0.00256	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—LEP—gestational diabetes	6.85e-05	0.00237	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—LEP—gestational diabetes	6.82e-05	0.00236	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GLS2—gestational diabetes	6.56e-05	0.00227	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—FGF2—gestational diabetes	6.1e-05	0.00211	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—FGF2—gestational diabetes	6.1e-05	0.00211	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—FGF2—gestational diabetes	6.1e-05	0.00211	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—FGF2—gestational diabetes	6.01e-05	0.00208	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—FGF2—gestational diabetes	5.63e-05	0.00195	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—FGF2—gestational diabetes	5.63e-05	0.00195	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—FGF2—gestational diabetes	5.63e-05	0.00195	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—FGF2—gestational diabetes	5.55e-05	0.00192	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—FGF2—gestational diabetes	5.2e-05	0.0018	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—LEP—gestational diabetes	5.19e-05	0.0018	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—LEP—gestational diabetes	5.19e-05	0.0018	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—LEP—gestational diabetes	5.19e-05	0.0018	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—FGF2—gestational diabetes	5.18e-05	0.00179	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—LEP—gestational diabetes	5.12e-05	0.00177	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—gestational diabetes	4.54e-05	0.00157	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—FGF2—gestational diabetes	3.94e-05	0.00136	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—FGF2—gestational diabetes	3.94e-05	0.00136	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—FGF2—gestational diabetes	3.94e-05	0.00136	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—FGF2—gestational diabetes	3.89e-05	0.00134	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—NAMPT—gestational diabetes	3.59e-05	0.00124	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GCK—gestational diabetes	3.57e-05	0.00124	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CYP19A1—gestational diabetes	2.61e-05	0.000903	CbGpPWpGaD
